Schedule 13G ownership disclosure

BioLife Solutions Inc

Common Stock · CUSIP: 09062W204

Event date: 2025-12-31

Filing-level shares
3,932,191.00
Percent of class
8.2%
  • Invesco Ltd.

    Shares: 3,932,191.00 · Class: 8.2%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000914208-26-000046
Form type
SCHEDULE 13G/A
Filer
BIOLIFE SOLUTIONS INC
CIK
CIK 834365
Filed
Feb 12, 2026
Reporting period
Dec 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub